Prefilled Syringes Market (By Type: Conventional, Safety; By Material: Glass, Plastic; By Design: Single-Chamber, Dual- Chamber, Customized; By Product: Complete Syringe Set, Components and Accessories; By Closing System: Staked Needle System, Luer Cone System, Luer Lock Form System: By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030


The global prefilled syringes market size was valued at US$ 6.49 billion in 2021 and is expected to hit around US$ 15.56 billion by 2030 poised to grow at a CAGR of 10.2% during the forecast period 2022 to 2030.

Prefilled Syringes Market Size 2022 to 2030

Growth Factors

A pre-filled syringe is also recognized as a package which is comprised of single-dose of medicine in which an attached needle also provided by the manufacturer. Previously, metal or glass syringes were very common in the industry of industry, but slowly & steadily consumer shift have been observed more towards disposable or plastic syringes in order to secure the needle and make it use and throw so that it cannot be re-utilized. In addition, this has revitalized the demand towards safe and convenient pre-filled syringes in the pharmaceutical market over conventional glass vials for storing drugs.

The impact of the driving factors is anticipated to surpass the effect of restraints. Also, the technological advancements leading to advanced adoption rate and untapped markets in the developing countries are anticipated to give new avenues for the growth of market in the near future. Likewise, growing use of technological advancements and prefilled syringes in auto-injectors are the crucial factors propelling the market. Furthermore, prefilled syringes are fleetly swapping traditional combinations of syringe-vial owing to advantages provided by them, similar as convenience for healthcare practitioners and increased patient safety in cure medication and delivery.

These syringes enable easy operation of chronic diseases, similar as rheumatoid arthritis, and diabetes which is anticipated to boost the use of auto-injectors and pen injectors during the forecast period. Therefore, the growing frequency of chronic disease like diabetes and other diseases is likely to fuel the market demand over the upcoming time period. In addition, the launch of advanced equipment with Wi-Fi and Bluetooth connectivity easing effective operation of patient health records is also anticipated to boost the product demand.

Report Scope of the Prefilled Syringes Market

Report Coverage Details
Market Size USD 15.56 Billion by 2030
Growth Rate

CAGR of 10.2% from 2022 to 2030

Base Year 2021
Largest Market Europe
Fastest Growing Market North America
Forecast Period 2022 to 2030
Segments Covered Type, Material, Design, Product, Closing System, Application, End User, Region
Companies Mentioned SCHOTT AG, West Pharmaceutical Services, Inc., Baxter International Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation, Elcam Medical, Oval Medical Technologies, SHL Medical AG, Terumo

 

In addition, the usage of pre-filled syringe has skyrocketed owing to the numerous difficulties in the traditional process. There are various advantages pre-filled syringes have in place of traditional packaging in vials which comprise of ease in use. As prefilled syringes efficiently mitigate the processes which is further required before using any drug in a vial. Moreover, it further helps in removing errors while providing doses to the patient’s as prefilled syringes are importantly comprise of the exact dose required for the patient. In addition, numerous producers of pharmaceuticals overfill their vials by up to 18%, however, this overfilled of vials is likely to cause many errors while giving a dose to the patient which can easily be mitigated with the help of the pre-filled syringes. Also, there exists excessive syringes development and various new products have been launched and are being kept in syringes now for the microbial safety. Pre-filled syringes are used in the packaging of injectable and diluents drugs. Some of the majorly listed drugs packaged in pre-filled syringes includes vaccines, blood stimulants, ervthroproteins, therapeutic proteins, and rheumatoid arthritis. Thus, comfort in utilization and better safety of the drug is the major factor which is leading to rise in demand for prefilled syringes in the market.

The impact of the COVID-19 on the market is likely to be more varied owing to the upsurge manufacturing of vaccines. In addition, growing demand for similar syringes instead of glass ampoules or other alternate needles have been observed on account of the decreased trouble of needle injuries. Accordingly, in order to boost the production of the COVID-19 vaccination, the producers are increasing their manufacturing capability.

The demand for prefilled syringes has risen due to the COVID-19 pandemic. The surge in number of COVID-19 patients is paving new ways for the growth of the global prefilled syringes market during 2020. Another factor boosting the growth of the global prefilled syringes market is growing incidences of rheumatoid arthritis and diabetes all over the world. In addition, the growing concerns about the safety of injectables are propelling the prefilled syringes market. The growing technological developments in the prefilled syringes market are also driving the demand for prefilled syringes. The prefilled syringes are widely adopted in the developed and developing regions such as North America and Europe. Moreover, the surge in demand for biosimilars is also contributing to the growth of the prefilled syringes market.

Type Insight

On the basis of type, safety prefilled syringes segment is likely to foresee the loftiest growth during the forthcoming time period majorly owing to the growing senior population worldwide and biological therapies availabilities for patients with suffering from chronic diseases and low- threat medical procedures outsourcing for chronic patients ease some of the pressure on hospitals.

Material Insight

The glass prefilled syringes segment reckoned for the largest share of the prefilled syringes in 2020. The large share of this segment is attributed to the significant benefits offered, similar as forestallment of oxygen and water vapor from interacting with medicine composites, comity with different stuffing machines, and flawless integration into pharmaceutical companies PFS operations.

Design Insight

The single- chamber prefilled syringes segment reckoned for the largest share of the prefilled syringes market. Furthermore, the market growth is majorly attributed to the significant benefits with the usage of prefilled syringes of single-chamber over vials, similar as optimized API use with lower overfill, lower medicine waste in clinical trials, reduced material requirements, and simple storage& disposal. Also, upsurge in self-administered parenteral medicines adoption owing to the adding frequency of various chronic diseases and advantages offered by them.

Region Insight

Europe is one of the major profit-generating regions in the prefilled syringes market. Rising frequency of chronic conditions, technological advancements, growth of the biologics and biosimilars market, geographical expansion by crucial manufacturers, growing population, and high adoption of tone-injection bias are driving the demand for tone-injectable prefilled syringes are the major factors driving the growth of the prefilled syringes market in Europe.

Key Market Developments

  • In December 2020, Becton, Dickinson and Company (BD) to invest around USD 1.2 billion to expand its manufacturing technology and capacity of prefilled syringes. This strategy enhanced the company to create strong position in the market.
  • In March 2019, SCHOTT launched syriQBioPure that is world’s first lubricant free prefilled glass syringe. This innovative launch enabled the company to extend its product portfolio in this industry.

Some of the prominent players in the global prefilled syringes market include:

  • SCHOTT AG
  • West Pharmaceutical Services, Inc.
  • Baxter International Inc.
  • Weigao Group
  • Vetter Pharma International GmbH
  • Nipro Corporation
  • Elcam Medical
  • Oval Medical Technologies
  • SHL Medical AG
  • Terumo

Segments Covered in the Report

By Type

  • Conventional Prefilled Syringes
    • Disposable Prefilled Syringes
    • Reusable Prefilled Syringes
  • Safety Prefilled Syringes

By Material

  • Glass
  • Plastic

By Design

  • Single-Chamber
  • Dual- Chamber
  • Customized

By Product

  • Complete Syringe Set
  • Components and Accessories

By Application

  • Diabetes
  • Rheumatoid Arthritis
  • Anaphylaxis
  • Cancer
  • Thrombosis
  • Ophthalmology
  • Others

By Closing System

  • Staked Needle System
  • Luer Cone System
  • Luer Lock Form System

By End User

  • Pharmaceutical and Biotechnology Companies
  • Contract Research and Manufacturing Organizations
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of prefilled syringes market?
According to Precedence Research, the global prefilled syringes market size was reached at US$ 6.49 billion in 2021 and is anticipated to surpass US$ 15.56 billion by 2030.
The global prefilled syringes market is expected to grow at a CAGR of 10.2% over the forecast period 2022 to 2030.
The impact of the driving factors is anticipated to surpass the effect of restraints. Also, the technological advancements leading to advanced adoption rate and untapped markets in the developing countries are anticipated to give new avenues for the growth of market in the near future
The major players operating in the prefilled syringes market are SCHOTT AG, West Pharmaceutical Services, Inc., Baxter International Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation, Elcam Medical, Oval Medical Technologies, SHL Medical AG, and Terumo.
Europe will lead the global prefilled syringes market over the forecast period 2022 to 2030.
  • Report Code:1575
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample